Hospice Announces March 2026 Revenue of NT$317 Million (Year-over-Year Increase of +5.1%)
Hospice (Stock Code: 1734), a company in the biotechnology and healthcare sector, reported its March 2026 revenue at NT$317.169 million, marking a 5.1% increase compared to the same period last year. This growth underscores the company's expanding presence and performance within the dynamic biotech and medical industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 17:23 (53 min after Collected)
Company Code: 1734
Company Name: Hospice
Industry: Biotechnology and Healthcare
Data Month: 2026-03
Monthly Revenue: 317,169 thousand yuan (NT$317 million)
Year-over-Year Change (Same Month Last Year): +5.1%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
Company Name: Hospice
Industry: Biotechnology and Healthcare
Data Month: 2026-03
Monthly Revenue: 317,169 thousand yuan (NT$317 million)
Year-over-Year Change (Same Month Last Year): +5.1%
Keywords: Monthly Revenue, Biotechnology and Healthcare Industry
FAQ
What was Hospice's revenue for March 2026?
Hospice's revenue for March 2026 was 317,169,000 yuan (317 million yuan).
What was the year-over-year percentage change in revenue?
Revenue increased by 5.1% compared to the same month last year.
Which industry does Hospice belong to?
Hospice belongs to the biotechnology and healthcare industry.